Correction: Review of the novel antifungal drug olorofim (F901318)
Saved in:
| Main Authors: | Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, Katrien Lagrou, Isabel Spriet, Johan Maertens |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | https://doi.org/10.1186/s12879-024-10295-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Doubling of triazole resistance rates in invasive aspergillosis over a 10-year period, Belgium, 1 April 2022 to 31 March 2023
by: Katrien Lagrou
Published: (2025-05-01) -
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
by: Eliane Vanhoffelen, et al.
Published: (2025-04-01) -
RNAi epimutations conferring antifungal drug resistance are inheritable
by: Carlos Pérez-Arques, et al.
Published: (2025-08-01) -
Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms
by: Patrick Van Dijck, et al.
Published: (2018-06-01) -
Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals
by: Cecilia Gutierrez-Perez, et al.
Published: (2025-04-01)